Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Oba

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
The British Journal of Surgery|February 17, 2022
Safety and efficacy of inside-stent as bridging therapy for malignant hilar biliary obstruction: single-centre prospective studyYu Takahashi, Takashi Sasaki, Naoki Sasahira, et al.
Surgery Today|September 27, 2025
Impact of sequential perioperative chemotherapy for high-risk colorectal liver metastasesKosuke Kobayashi, Yoshihiro Ono, Atsushi Oba, et al.
Surgery|November 17, 2022
Optimizing the selection of technically unresectable colorectal liver metastasesKosuke Kobayashi, Yosuke Inoue, Yuki Kitano, et al.
Langenbeck'S Archives of Surgery|May 30, 2023
Feasibility of laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) as a standard treatment for distal resectable pancreatic cancerShoki Sato, Atsushi Oba, Tomotaka Kato, et al.
Surgery|November 24, 2022
Evaluation of local recurrence after pancreaticoduodenectomy for borderline resectable pancreatic head cancer with neoadjuvant chemotherapy: Can the resection level change after chemotherapy?Kosuke Kobayashi, Yoshihiro Ono, Shoki Sato, et al.
Annals of Surgical Oncology|April 3, 2022
ASO Author Reflections: What are the Indications for Conversion Surgery for Initially Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel? Is Surgery Really Worthwhile after Sufficient Chemotherapy?Yuta Ushida, Yosuke Inoue, Atsushi Oba, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 10, 2023
Diagnosis and management of postpancreatectomy hemorrhage: A single-center experience of consecutive 1,096 pancreatoduodenectomiesKosuke Kobayashi, Yosuke Inoue, Kojiro Omiya, et al.
Surgical Case Reports|August 26, 2024
Integrating surgical intervention and watch-and-wait approach in dMMR metastatic rectal cancer with pembrolizumab: a case reportYohei Ando, Tsubasa Sakurai, Kosuke Ozaki, et al.
Annals of Surgical Oncology|June 26, 2023
Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative TreatmentKosuke Kobayashi, Yoshihiro Ono, Yuki Kitano, et al.
Annals of Surgical Oncology|November 23, 2024
Strategies for Recurrent Colorectal Liver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of Multidisciplinary TreatmentKosuke Kobayashi, Yosuke Inoue, Atsushi Oba, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
The British Journal of Surgery|February 17, 2022
Safety and efficacy of inside-stent as bridging therapy for malignant hilar biliary obstruction: single-centre prospective studyYu Takahashi, Takashi Sasaki, Naoki Sasahira, et al.
Surgery Today|September 27, 2025
Impact of sequential perioperative chemotherapy for high-risk colorectal liver metastasesKosuke Kobayashi, Yoshihiro Ono, Atsushi Oba, et al.
Surgery|November 17, 2022
Optimizing the selection of technically unresectable colorectal liver metastasesKosuke Kobayashi, Yosuke Inoue, Yuki Kitano, et al.
Langenbeck'S Archives of Surgery|May 30, 2023
Feasibility of laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) as a standard treatment for distal resectable pancreatic cancerShoki Sato, Atsushi Oba, Tomotaka Kato, et al.
Surgery|November 24, 2022
Evaluation of local recurrence after pancreaticoduodenectomy for borderline resectable pancreatic head cancer with neoadjuvant chemotherapy: Can the resection level change after chemotherapy?Kosuke Kobayashi, Yoshihiro Ono, Shoki Sato, et al.
Annals of Surgical Oncology|April 3, 2022
ASO Author Reflections: What are the Indications for Conversion Surgery for Initially Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel? Is Surgery Really Worthwhile after Sufficient Chemotherapy?Yuta Ushida, Yosuke Inoue, Atsushi Oba, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 10, 2023
Diagnosis and management of postpancreatectomy hemorrhage: A single-center experience of consecutive 1,096 pancreatoduodenectomiesKosuke Kobayashi, Yosuke Inoue, Kojiro Omiya, et al.
Surgical Case Reports|August 26, 2024
Integrating surgical intervention and watch-and-wait approach in dMMR metastatic rectal cancer with pembrolizumab: a case reportYohei Ando, Tsubasa Sakurai, Kosuke Ozaki, et al.
Annals of Surgical Oncology|June 26, 2023
Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative TreatmentKosuke Kobayashi, Yoshihiro Ono, Yuki Kitano, et al.
Annals of Surgical Oncology|November 23, 2024
Strategies for Recurrent Colorectal Liver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of Multidisciplinary TreatmentKosuke Kobayashi, Yosuke Inoue, Atsushi Oba, et al.
Pageof 16